Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 2494615)

Published in Brain Res on April 01, 2008

Authors

Robert Siman1, Victoria L Roberts, Elizabeth McNeil, Antony Dang, Joseph E Bavaria, Sindhu Ramchandren, Michael McGarvey

Author Affiliations

1: Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. siman@mail.med.upenn.edu

Articles citing this

Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J Pediatr (2013) 1.90

A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma (2009) 1.39

Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma (2011) 1.31

Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci (2010) 1.28

Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J Neurotrauma (2012) 1.18

Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery (2012) 1.14

Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study. Pediatr Crit Care Med (2013) 1.07

Heat shock proteins as biomarkers for the rapid detection of brain and spinal cord ischemia: a review and comparison to other methods of detection in thoracic aneurysm repair. Cell Stress Chaperones (2010) 1.07

A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res (2010) 1.04

Therapy development for diffuse axonal injury. J Neurotrauma (2013) 1.03

Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients. Mol Med (2011) 0.94

Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest. Ann Thorac Surg (2009) 0.90

Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PLoS One (2011) 0.90

Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int (2013) 0.87

Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest. J Thorac Cardiovasc Surg (2011) 0.83

Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke. Proteome Sci (2014) 0.79

Neuroprotection in Pediatric Cardiac Surgery: What is On the Horizon? Prog Pediatr Cardiol (2010) 0.76

Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex. Mol Neurobiol (2016) 0.75

Articles cited by this

Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci (1999) 10.61

Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med (1996) 5.82

The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis (2004) 5.49

High serum S100B levels for trauma patients without head injuries. Neurosurgery (2001) 4.16

Edema and brain trauma. Neuroscience (2004) 2.78

Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med (2002) 2.42

Increased levels of serum S100B protein in critically ill patients without brain injury. Shock (2006) 2.21

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci (2005) 2.17

Central nervous system complications of cardiac surgery. Br J Anaesth (2000) 2.03

Temporary neurological dysfunction after deep hypothermic circulatory arrest: a clinical marker of long-term functional deficit. Ann Thorac Surg (1999) 1.98

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology (2004) 1.97

Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.82

Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem (1983) 1.80

Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke (2006) 1.73

Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron (1988) 1.67

Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci (1989) 1.55

Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation (2005) 1.53

Delayed neuronal death. Neuropathology (2000) 1.49

Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma (2004) 1.46

Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci (1994) 1.45

Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms. Ann Thorac Surg (2005) 1.42

Peripheral markers of blood-brain barrier damage. Clin Chim Acta (2004) 1.39

Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis (2005) 1.39

Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis (2004) 1.38

Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun (2005) 1.36

Selective antegrade cerebral perfusion attenuates brain metabolic deficit in aortic arch surgery: a prospective randomized trial. Circulation (2004) 1.33

Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke (1999) 1.32

Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol (1996) 1.32

Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.30

Advances in the vascular pathophysiology of ischemic stroke. Thromb Res (2000) 1.27

A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods (2003) 1.24

Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem (1994) 1.21

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res (2002) 1.21

Postoperative cognitive dysfunction after cardiac surgery. Chest (2005) 1.20

Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2004) 1.18

14-3-3 proteins: biological function and domain structure. Biochem Soc Trans (1995) 1.14

Function and evolution of neurofilament proteins. Ann N Y Acad Sci (1985) 1.12

Neurocognitive complications after coronary artery bypass surgery. Ann Neurol (2005) 1.09

Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology (2004) 1.06

Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma (2002) 1.06

Interventions for reversing delayed-onset postoperative paraplegia after thoracic aortic reconstruction. Ann Thorac Surg (2002) 1.06

Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation. J Biol Chem (2001) 1.05

Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat. J Cereb Blood Flow Metab (2005) 1.02

Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke (1998) 1.01

Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and neuroprotection. Ann N Y Acad Sci (1993) 0.98

Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl (1998) 0.92

Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr (2002) 0.91

Comparison of calpain and caspase activities in the adult rat brain after transient forebrain ischemia. Neurobiol Dis (2002) 0.91

Coronary-artery bypass surgery and the brain: persisting concerns. Lancet Neurol (2002) 0.90

Neuroprotection with delayed initiation of prolonged hypothermia after in vitro transient global brain ischemia. Resuscitation (2005) 0.89

Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients. Brain Res Bull (2003) 0.89

Diagnosis and management of cerebral malperfusion phenomena during aortic dissection repair by transesophageal Doppler echocardiographic monitoring. J Card Surg (1997) 0.88

Axonal pathology in subarachnoid and intracerebral hemorrhage. J Neurotrauma (2005) 0.87

Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke. Brain Res (2007) 0.86

Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ. Cell Motil Cytoskeleton (2000) 0.83

S-100B concentration is not related to neurocognitive performance in the first month after mild traumatic brain injury. Eur Neurol (2005) 0.82

S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage. Acta Neurochir (Wien) (1988) 0.81

The treatment of spinal cord ischemia following thoracic endovascular aortic repair. Neurocrit Care (2007) 0.79

Purification and properties of a brain-specific protein, human 14-3-3 protein. Biochem Soc Trans (1980) 0.77

Cerebral damage following open-heart surgery in deep hypothermia and circulatory arrest. Scand J Thorac Cardiovasc Surg (1983) 0.76

Ischemic rat brains contain immunoreactivity of 14-3-3 proteins. Int J Neurosci (1998) 0.76

Articles by these authors

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

Molecular target class is predictive of in vitro response profile. Cancer Res (2010) 3.27

Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg (2008) 3.04

Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2006) 2.71

Saddle-shape annuloplasty increases mitral leaflet coaptation after repair for flail posterior leaflet. Ann Thorac Surg (2011) 2.42

The dog as a cancer model. Nat Biotechnol (2006) 2.08

The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06

Pathogenesis of acute aortic dissection: a finite element stress analysis. Ann Thorac Surg (2011) 1.95

Antegrade thoracic stent grafting during repair of acute DeBakey I dissection prevents development of thoracoabdominal aortic aneurysms. Ann Thorac Surg (2009) 1.95

Aortic dilatation with bicuspid aortic valves: cusp fusion correlates to matrix metalloproteinases and inhibitors. Ann Thorac Surg (2011) 1.88

Cardiac surgery in Jehovah's Witness patients: ten-year experience. Ann Thorac Surg (2011) 1.85

Spinal cord ischemia may be reduced via a novel technique of intercostal artery revascularization during open thoracoabdominal aneurysm repair. J Vasc Surg (2007) 1.84

Increased ascending aortic wall stress in patients with bicuspid aortic valves. Ann Thorac Surg (2011) 1.84

Risk factors for perioperative stroke after thoracic endovascular aortic repair. Ann Thorac Surg (2007) 1.77

Have hybrid procedures replaced open aortic arch reconstruction in high-risk patients? A comparative study of elective open arch debranching with endovascular stent graft placement and conventional elective open total and distal aortic arch reconstruction. J Thorac Cardiovasc Surg (2010) 1.71

Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61

Aortic decision-making in the Loeys-Dietz syndrome: aortic root aneurysm and a normal-caliber ascending aorta and aortic arch. J Thorac Cardiovasc Surg (2008) 1.59

Significance of malperfusion syndromes prior to contemporary surgical repair for acute type A dissection: outcomes and need for additional revascularizations. Eur J Cardiothorac Surg (2007) 1.59

Perioperative outcome in adults undergoing elective deep hypothermic circulatory arrest with retrograde cerebral perfusion in proximal aortic arch repair: evaluation of protocol-based care. J Cardiothorac Vasc Anesth (2006) 1.57

Long-term comparison of thoracic endovascular aortic repair (TEVAR) to open surgery for the treatment of thoracic aortic aneurysms. J Thorac Cardiovasc Surg (2012) 1.53

Graft selection for aortic root replacement in complex active endocarditis: does it matter? Ann Thorac Surg (2011) 1.51

Resection of primary leiomyosarcoma of the inferior vena cava (IVC) with reconstruction: a case series and review of the literature. J Surg Oncol (2014) 1.49

Ascending aortic cannulation in acute type a dissection repair. Ann Thorac Surg (2013) 1.49

Peak wall stress predicts expansion rate in descending thoracic aortic aneurysms. Ann Thorac Surg (2012) 1.48

Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet (2011) 1.48

Type A aortic dissection in Marfan syndrome: extent of initial surgery determines long-term outcome. Circulation (2014) 1.46

Coronary artery aneurysms associated with ascending aortic aneurysms and abdominal aortic aneurysms: pathophysiologic implications. Catheter Cardiovasc Interv (2014) 1.43

Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms. Ann Thorac Surg (2005) 1.42

Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg (2007) 1.42

Simultaneous thoracic endovascular aortic repair and endovascular aortic repair is feasible with minimal morbidity and mortality. J Vasc Surg (2011) 1.42

Results of a new surgical paradigm: endovascular repair for acute complicated type B aortic dissection. Ann Thorac Surg (2008) 1.41

The effect of surgical and transcatheter aortic valve replacement on mitral annular anatomy. Ann Thorac Surg (2012) 1.40

Hemodynamic collapse during pulmonary embolectomy due to loss of venous return from acute occlusion of the cardiopulmonary venous cannula with thromboembolus. Interact Cardiovasc Thorac Surg (2008) 1.39

Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp Neurol (2006) 1.39

A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma (2009) 1.39

Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis (2004) 1.38

Aortic valve commissural fenestrations due to sinus of valsalva dilatation. Ann Thorac Surg (2009) 1.38

Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg (2013) 1.33

Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms. Ann Thorac Surg (2011) 1.32

Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation (2006) 1.32

Fate of the residual distal and proximal aorta after acute type a dissection repair using a contemporary surgical reconstruction algorithm. Ann Thorac Surg (2007) 1.26

Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212. Mol Cancer Ther (2011) 1.24

Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet (2011) 1.20

Left subclavian artery coverage during thoracic endovascular aortic repair: a single-center experience. J Vasc Surg (2008) 1.18

Effects of institutional volumes on operative outcomes for aortic root replacement in North America. J Thorac Cardiovasc Surg (2012) 1.15

Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg (2006) 1.15

Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. Circulation (2013) 1.15

Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg (2011) 1.14

Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparison. J Thorac Cardiovasc Surg (2013) 1.13

Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation. J Cell Physiol (2012) 1.13

Targeting landing zone 0 by total arch rerouting and TEVAR: midterm results of a transcontinental registry. Ann Thorac Surg (2012) 1.12

Transapical deployment of endovascular thoracic aortic stent graft for an ascending aortic pseudoaneurysm. Ann Thorac Surg (2010) 1.12

Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg (2013) 1.11

Thoracic endovascular aortic repair for acute complicated type B aortic dissection: superiority relative to conventional open surgical and medical therapy. J Thorac Cardiovasc Surg (2010) 1.11

The management of endograft infections following endovascular thoracic and abdominal aneurysm repair. J Vasc Surg (2013) 1.07

Heat shock proteins as biomarkers for the rapid detection of brain and spinal cord ischemia: a review and comparison to other methods of detection in thoracic aneurysm repair. Cell Stress Chaperones (2010) 1.07

Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann Thorac Surg (2009) 1.06

Interventions for reversing delayed-onset postoperative paraplegia after thoracic aortic reconstruction. Ann Thorac Surg (2002) 1.06

Advances in aortic valve repair: focus on functional approach, clinical outcomes, and central role of echocardiography. J Cardiothorac Vasc Anesth (2010) 1.06

Retrograde and antegrade cerebral perfusion: results in short elective arch reconstructive times. Ann Thorac Surg (2010) 1.04

Interleukin-10 limits local and body cavity inflammation during infection with muscle-stage Trichinella spiralis. Infect Immun (2004) 1.04

Gender-related changes in aortic geometry throughout life. Eur J Cardiothorac Surg (2014) 1.03

The hybrid total arch repair: brachiocephalic bypass and concomitant endovascular aortic arch stent graft placement. J Card Surg (2007) 1.02

Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: definition, incidence, and clinical predictors. J Cardiothorac Vasc Anesth (2006) 1.02

Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat. J Cereb Blood Flow Metab (2005) 1.02

Thoracic endografting reduces morbidity and remodels the thoracic aorta in DeBakey III aneurysms. Ann Thorac Surg (2012) 1.01

Aortic size in acute type A dissection: implications for preventive ascending aortic replacement. Eur J Cardiothorac Surg (2009) 1.01

Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res (2013) 0.99

Hybrid repair of aortic arch aneurysms: combined open arch reconstruction and endovascular repair. Semin Thorac Cardiovasc Surg (2009) 0.99

Valve-sparing and valve-replacing techniques for aortic root replacement in patients with Marfan syndrome: Analysis of early outcome. J Thorac Cardiovasc Surg (2009) 0.97

Long-term implications of emergency versus elective proximal aortic surgery in patients with Marfan syndrome in the Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions Consortium Registry. J Thorac Cardiovasc Surg (2011) 0.96

Major clinical outcomes in adults undergoing thoracic aortic surgery requiring deep hypothermic circulatory arrest: quantification of organ-based perioperative outcome and detection of opportunities for perioperative intervention. J Cardiothorac Vasc Anesth (2005) 0.95

Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol (2012) 0.94

Percutaneous closure of a left ventricular pseudoaneurysm after Sapien XT transapical transcatheter aortic valve replacement. JACC Cardiovasc Interv (2012) 0.92

Reimplantation valve-sparing aortic root replacement in Marfan syndrome using the Valsalva conduit: an intercontinental multicenter study. Ann Thorac Surg (2007) 0.92

Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis. Cardiovasc Res (2013) 0.91

Mutation and copy number detection in human cancers using a custom genotyping assay. Genomics (2011) 0.90

Vascular distribution of stroke and its relationship to perioperative mortality and neurologic outcome after thoracic endovascular aortic repair. J Vasc Surg (2012) 0.89

Heat shock proteins HSP70 and HSP27 in the cerebral spinal fluid of patients undergoing thoracic aneurysm repair correlate with the probability of postoperative paralysis. Cell Stress Chaperones (2008) 0.89

Patients with type A acute aortic dissection presenting with major brain injury: should we operate on them? J Thorac Cardiovasc Surg (2013) 0.89

Neuroprotection with delayed initiation of prolonged hypothermia after in vitro transient global brain ischemia. Resuscitation (2005) 0.89

Safety of lumbar drains in thoracic aortic operations performed with extracorporeal circulation. Ann Thorac Surg (2003) 0.88

Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease. Ann Thorac Surg (2011) 0.87

Gender analysis of the pivotal results of the Medtronic Talent Thoracic Stent Graft System (VALOR) trial. J Vasc Surg (2011) 0.87

Observational study of mortality risk stratification by ischemic presentation in patients with acute type A aortic dissection: the Penn classification. Nat Clin Pract Cardiovasc Med (2008) 0.87

Techniques for preserving vertebral artery perfusion during thoracic aortic stent grafting requiring aortic arch landing. Vasc Endovascular Surg (2006) 0.87

Reintervention for endograft failures after thoracic endovascular aortic repair. J Thorac Cardiovasc Surg (2013) 0.86

Hypothermia and the approximate entropy of the electroencephalogram. Anesthesiology (2003) 0.86

Reoperative aortic root replacement in patients with previous aortic surgery. Ann Thorac Surg (2007) 0.85

Perioperative changes in cerebral blood flow after cardiac surgery: influence of anemia and aging. Ann Thorac Surg (2003) 0.85

Anatomic exclusion from endovascular repair of thoracic aortic aneurysm. J Vasc Surg (2007) 0.85

Cardiopulmonary bypass, hemolysis, and nitroprusside-induced cyanide production. Anesth Analg (2007) 0.84

CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation. Transplantation (2002) 0.84